Giovanni Allevi

Hypoxia-Inducible Factor-1α Expression Predicts a Poor Response to Primary Chemoendocrine Therapy and Disease-Free Survival in Primary Human Breast Cancer

Daniele Generali, Alfredo Berruti, Maria Pia Brizzi et al. · Clinical Cancer Research · 2006 · 243 citations · Full text

Medicine, Oncology, Pharmacology +15

Randomized Phase II Trial of Letrozole and Letrozole Plus Low-Dose Metronomic Oral Cyclophosphamide As Primary Systemic Treatment in Elderly Breast Cancer Patients

Alberto Bottini, Daniele Generali, Maria Pia Brizzi et al. · Journal of Clinical Oncology · 2006 · 190 citations · Full text

Medicine, Oncology, Pharmacology +15

Immunomodulation of FOXP3+ Regulatory T Cells by the Aromatase Inhibitor Letrozole in Breast Cancer Patients

Daniele Generali, Gaynor J. Bates, Alfredo Berruti et al. · Clinical Cancer Research · 2009 · 157 citations

Life Sciences, Immunology, Pharmacology +17

Phosphorylated ERα, HIF-1α, and MAPK Signaling As Predictors of Primary Endocrine Treatment Response and Resistance in Patients With Breast Cancer

Daniele Generali, Francesca M. Buffa, Alfredo Berruti et al. · Journal of Clinical Oncology · 2008 · 116 citations · Full text

Medicine, Oncology, Pharmacology +17

Relationship between tumour shrinkage and reduction in Ki67 expression after primary chemotherapy in human breast cancer

Alberto Bottini, Alfredo Berruti, Alessandra Bersiga et al. · British Journal of Cancer · 2001 · 86 citations · Full text

Medicine, Oncology, Pharmacology +11